EFEITOS PSICOLÓGICOS DA PSILOCIBINA EM PORTADORES DE CÂNCER TERMINAL: Uma revisão de escopo
Psicologia e Saúde em Debate January 10, 2024 Leonardo Hercílio Florêncio Silva, Júnia Aparecida Laia Da Mata, Sabrina Stefanello et al.
Psilocybin, a natural hallucinogenic alkaloid, when combined with psychotherapy, reduces symptoms of depression and anxiety in patients with terminal cancer. A scoping review of nine studies found that psilocybin is well tolerated and has no significant adverse effects in controlled settings. The review searched five databases and identified 340 articles, selecting nine that all point to psilocybin's effectiveness in lowering symptomatic levels of depression and anxiety. More research with larger and more diverse samples is needed.